News

Jun 30, 2015

ComplexINC’s MultiBac technology will have ‘wide impact on structural biology’, says Nobel Laureate

Roger Kornberg, winner of the 2006 Nobel Prize in Chemistry, presented an inspiring lecture in Shanghai, describing his ground-breaking work on the “Molecular basis of the RNA Transcription Machinery”. Kornberg, Professor of Structural Biology at Stanford University, USA, is also distinguished Professor-in-Residence at Shanghai Tech University in China. Kornberg’s talk covered his main...
Jun 26, 2015

ComplexINC flagged as ‘Highlight’ and ‘Success Case’

ComplexINC is an ambitious high-tech project funded by the European Commission in Framework Programme 7. It combines leading scientists from renowned European research institutions and SMEs. The major goal of ComplexINC is to jointly create new and innovative production tools and technologies for next-generation protein biologics. ComplexINC was kicked off in 2011, and the consortium and research...
Apr 08, 2015

ComplexINC Coordinator Imre Berger receives prestigious Wellcome Trust Senior Investigator Award

The Wellcome Trust announced that ComplexINC Coordinator Imre Berger has been given a Senior Investigator Award. These highly competitive awards provide generous funding for scientists who have an excellent track record and are in an established academic post. The Senior Investigator Award offers the flexibility, time and ample resources to enable outstanding scientists to tackle the most...
Mar 19, 2015

Molecular details of key step in protein targeting revealed.

Around one third of the proteins in living cells are delivered to the plasma membrane. This is carried out by a universally conserved, complex mechanism involving ribosomes that are translating mRNA into membrane-bound nascent polypeptide chains. In the process, two further molecules associate with the ribosome and the emerging polypeptide. These are the signal recognition particle, SRP, which...
Jan 27, 2015

EMBL grants exclusive license for synthetic baculoviral genomes to Geneva Biotech

EMBL Enterprise Management Technology Transfer GmbH (EMBLEM), the exclusive partner of the European Molecular Biology Laboratory (EMBL) for technology transfer, has granted Geneva Biotech an exclusive license for exploitation of intellectual property covering novel minimal baculoviral genomes.These synthetic viral nanosystems (SVNs) were created in the laboratory of ComplexINC coordinator Imre...
Displaying results 16 to 20 out of 46